Differential immune activation during simulated cardiopulmonary bypass procedure using freshly drawn and week-old blood-a pilot study

Artificial Organs

Volumn 34, Issue 11, 2010, Pages 1048-1053

  Aran, Kiana ^a   Fok, Alex ^a   Guan, Yulong ^b   Sun, Qi ^b   Zahn, Jeffrey D ^a,b   Ündar, Akif ^b  

^a RUTGERS UNIVERSITY   (United States)

^b PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Cytokines; Fresh versus old blood; Immune activation; Pediatric cardiopulmonary bypass

Indexed keywords

BLOOD; CHEMICAL ACTIVATION; IMMUNE SYSTEM;

CARDIOPULMONARY BYPASS; CARDIOPULMONARY BYPASS CIRCUIT; CYTOKINES; FRESH VERSUS OLD BLOOD; HUMORAL IMMUNE RESPONSE; IMMUNE ACTIVATION; PEDIATRIC CARDIOPULMONARY BYPASS; PENN STATE; PILOT STUDIES; WHOLE BLOOD;

PEDIATRICS;

INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ACTIVE IMMUNIZATION; AGE DISTRIBUTION; ARTICLE; BLOOD; BLOOD CHEMISTRY; BLOOD DONOR; BLOOD SAMPLING; CARDIOPULMONARY BYPASS; CIRCULATION TIME; CYTOKINE RELEASE; EXTRACORPOREAL CIRCULATION; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOFLUORESCENCE MICROSCOPY; PILOT STUDY; PRIORITY JOURNAL; SIMULATION;

EID: 78649602727     PISSN: 0160564X     EISSN: 15251594     Source Type: Journal    
DOI: 10.1111/j.1525-1594.2010.01122.x     Document Type: Article

References (14)

1. De Mendonca-Filho HT, Pereira KC, Fontes M, et al. Circulating inflammatory mediators and organ dysfunction after cardiovascular surgery with cardiopulmonary bypass: a prospective observational study. Crit Care 2006;10:R46.
2. Khabar KS, Elbarbary MA, Khouqeer F, Devol E, Al-Gain S, Al-Halees Z. Circulating endotoxin and cytokines after cardiopulmonary bypass: differential correlation with duration of bypass and systemic inflammatory response/multiple organ dysfunction syndromes. Clin Immunol Immunopathol 1997;85:97-103.
3. Moat NE, Shore DF, Evans TW. Organ dysfunction and cardiopulmonary bypass: the role of complement and complement regulatory proteins. Eur J Cardiothorac Surg 1993;7:563-73.
4. Westaby S. Complement and the damaging effects of cardiopulmonary bypass. Thorax 1983;38:321-5.
5. Westaby S. Organ dysfunction after cardiopulmonary bypass. A systemic inflammatory reaction initiated by the extracorporeal circuit. Intensive Care Med 1987;13:89-95.
6. Hensel M, Volk T, Docke WD, et al. Hyperprocalcitonemia in patients with noninfectious SIRS and pulmonary dysfunction associated with cardiopulmonary bypass. Anesthesiology 1998;89:93-104.
7. Levy JH, Tanaka KA. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 2003;75(Suppl.):S715-20.
8. Steinberg JB, Kapelanski DP, Olson JD, Weiler JM. Cytokine and complement levels in patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg 1993;106:1008-16.
9. Miller A, Lu K, Wang S, et al. Pediatric cardiopulmonary bypass circuits: a review of studies conducted at the Penn State Pediatric Cardiac Research Laboratories. J Extra Corpor Technol 2009;41:P50-8.
10. Haines NM, Wang S, Myers JL, Ündar A. Comparison of pumps and oxygenators with pulsatile and non-pulsatile modes in an infant cardiopulmonary bypass model. Artif Organs 2009;993-1001.
11. Guan Y, Palanzo D, Kunselman AR, Ündar A. Evaluation of membrane oxygenators and reservoirs in terms of capturing gaseous microemboli and pressure drops. Artif Organs 2009;33:1037-43.
12. Talor J, Yee S, Rider A, Kunselman AR, Guan Y, Ündar A. Comparison of perfusion quality in hollow-fiber membrane oxygenators for neonatal extracorporeal life support. Artif Organs 2010;34:E110-E116.
13. Fung M, Loubser PG, Ündar A, et al. Inhibition of complement, neutrophil, and platelet activation by an anti-factor D monoclonal antibody in simulated cardiopulmonary bypass circuits. J Thorac Cardiovasc Surg 2001;122:113-22.
14. Yang S, Ündar A, Zahn JD. A microfluidic device for continuous, real time blood plasma separation. Lab Chip 2006;6:871-80.